Confirmed Attending Companies Include:
|
20Med Therapeutics B.V.
3Brain GmbH 60 Degrees Pharmaceuticals, LLC AbbVie, Inc. ABIVAX Acceleris Capital Limited Accequa AB Acesion Pharma Acticor Biotech SAS ACXIT Capital Partners ACXIT Lifesciences GmbH Addex Therapeutics Ltd. Adveq Management AGCT GmbH Albion Ventures LLP Allecra Therapeutics Alliance for Regenerative Medicine Almirall ALSTIN Amadix Amal Therapeutics SA Anima Biotech Ltd. Anteo Diagnostics Ltd Anthony Horning Strategic Transactions Advisory Apex Healthcare Consulting Ltd Apogenix AG Aravis SA Arcus Ventures Arix Bioscience AstraZeneca Austin Life Science Partners AG Avego Healthcare Company Avicenna Ventures Avillion LLP Axovant Sciences B3C newswire Banque Lombard Odier BaseLaunch Bay City Capital LLC Bayer AG BB Biotech Ventures BerGenBio AS Bergmann zur Hausen & Cie. GmbH BioMedPartners AG BioStart Consulting GmbH Bird & Bird LLP BLR & Partners Boehringer Ingelheim GmbH Bpifrance Breslin AG Cancer Research Technology Ltd. Capricorn One Capricorn Venture Partners NV CardioRenal SAS Cederberg GmbH Cellectis SA Celonic AG Cerevance ChinaBio Capital Clayton Biotechnologies, Inc. Colpman Consulting Ltd. COMPLIX NV Confo Therapeutics Coparion GmbH & Co. KG Csendes Consulting Cukierman & Co. Life Sciences Curetis AG Cyxone AB DATA 4 ACTIONS, Inc. Debiopharm Innovation Fund Digital Networks PLC Drooms AG Dynacure E. Gutzwiller & Cie, Banquiers Economic and Trade Department, Embassy of Israel Edison Group Edmond de Rothschild Investment Partners Eli Lilly & Co. Eligo Bioscience EMBL Ventures GmbH EpimAb Biotherapeutics, Inc. Ernst & Young eTheRNA European Investment Bank Evotec International Gmbh F. Hoffmann La Roche AG Fraser Finance FreeMind Group F-star Biotechnology Ltd. fundamenta CAPITAL AG GeneCode Ltd. |
Genomic Vision
Gilde Healthcare Partners Global Life Science Ventures AG goetzpartners holding Grabulovski Consulting Services GreenBone Ortho srl GrowthCube Partners LLC Health Advances GmbH Helsinn Healthcare SA Hestia Investments High Point Solutions High-Tech Gründerfonds Management GmbH Hoffmann-La Roche Ltd. Hookipa Biotech AG ICF Consult Ignite Capital Partners, Inc. Immunic AG Immunomic Therapeutics, Inc. Industrifonden INKEF Capital BV Inositec Inserm Transfert Initiative Instinctif Partners Ltd. INSTITUT DE RECHERCHE PIERRE FABRE InterAX Biotech AG Inthera Bioscience AG Invectys SA IO Biotech ApS IPSA Ipsen ISA Pharmaceuticals B.V. Janssen Pharmaceutical Companies of Johnson & Johnson JJ Zwicky & Partners Johnson & Johnson Innovation Johnson and Johnson Karolinska Institutet Innovations AB Kinled Holding Kontor Stoewer Asset Management GmbH Kreos Capital Kronos Advisors Kurma Partners Labatec Pharma SA LifeCare Partners LifeSci Advisors LMU Munich LOGSCALE Venture Partners LSP LSRI Lytix Biopharma AS MAB Discovery GmbH Marcol Health Germany Martina Kaufmann Strategic Consulting MD1 Management Direct AG Medesis Pharma SA Medherant Limited Medicortex Finland Oy medicxi MedTech Innovation Partners AG MedVenture Partners GmbH Memo Therapeutics AG Merck KGaA Merck Ventures B.V. Mergermarket Merieux Developpement Mid Atlantic Bio Angels Midatech Pharma PLC MIG Verwaltungs Mirabaud Securities LLP Momentum Biotech Monitus Research MorphoSys AG MS Ventures MSD MyCartis MyeloPro Diagnostics and Research GmbH Mymetics Corporation Nasdaq OMX NetScientific PLC Nextech Invest Ltd. Norgine Ventures NovaHep AB Novaremed Ltd. Novartis Novartis Pharma AG Novartis Venture Fund Novassay SA NovImmune SA Novithera Novo A/S Novo Seeds |
NRW Bank
Oberland Capital Oddo & Cie Oncomatryx Biopharma, S.L. Opsona Therapeutics Ltd. Orbit Discovery Origenis GmbH OSE Immunotherapeutics Ostara Biomedical Oxford BioMedica plc Oxford University Innovation Ltd. PeptiMimesis Pfizer Inc. PharmaVentures Philimmune, LLC Pierre Fabre Fund for Innovation Pluvalca Biotech PRAGMA Therapeutics Prexton Therapeutics Probiodrug AG Provectus Biopharmaceuticals, Inc. Purdue Pharma Queen Mary University London RA Capital Management Randox Laboratories Ltd. RBV Capital Realm Therapeutics, Inc. Redalpine Venture Partners ReFlow Therapeutics AG RMI Partners Rockport Venture Partners Rosetta Capital Ltd RSA AG Sachs Associates Ltd Salus Partners SA Sanofi SCC LifeScience Sensorion SA Seroba Kernel Life Sciences Ltd. Seventure Partners Shire Pharmaceuticals Silicon Valley Bank Sirius Healthcare Partners SIX Swiss Exchange Sofinnova Partners SOM Biotech SPARK Impact Spectrum-Value Management Stratos Bio Strekin AG Suenos Advisors Est. Sunstone Capital A/S Sutura Therapeutics Ltd. SV Life Sciences Advisors Sygnature Discovery Limited SynAffix BV Synpromics Ltd. Taisho Pharmaceutical Co., Ltd. TaiwanJ Pharmaceuticals Takeda Ventures, Inc. Targovax ASA TechNation The Fulford Group Thermosome GmbH ThromboGenics NV Timmnue Biotech, Inc. Torreya Partners (Europe), LLC Trethera Corporation TVM Capital TVM Capital China Limited TxCell Unicyte AG uniQure BV UP Biotech Management AG valuationLAB AG Vaxart, Inc. Vaximm AG Ventac Partners GmbH Venture Valuation AG / Biotechgate Vesalius Biocapital VI Partners AG Vogel BioC Wellcome Trust Wellington Partners Xeraya Capital XOventure GmbH Yorkville Advisors, LLC Ysios Capital Partners ZFHN ZukunftsAgentur Brandenburg GmbH Zukunftsfonds Heilbronn GmbH & Co KG |